| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Kania Edwin M Jr is a Director at Cartesian Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 1 sell.
Estimated insider holdings value: $23.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2021 | TMDX Transmedics Group, Inc. | Director | Buy | 100,000 | $22.56 | $2,256,215.34 | +23.2% | -15.0% | +166.8% | |
| May 6, 2019 | TMDX Transmedics Group, Inc. | Director | Buy | 33,333 | $16.00 | $533,328.00 | New | - | - | |
| May 16, 2017 | RNAC Cartesian Therapeutics, Inc. | Director | Sell | 266,795 | $14.00 | $3,735,130.00 | -32.3% | - | - |